Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

6/27/24 8:33:51 AM ET

$AVAV

$ELAN

$GRFS

$HIMS

Aerospace

Industrials

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $AVAV alert in real time by email

U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Thursday.

Shares of Levi Strauss & Co. (NYSE:LEVI) fell sharply in today’s pre-market trading after the company reported mixed second-quarter financial results and issued FY24 EPS guidance with its midpoint below estimates.

Levi Strauss reported quarterly earnings of 16 cents per share which beat the analyst consensus estimate of 11 cents by 45.45%. Quarterly sales came in at $1.44 billion, missing the analyst consensus estimate of $1.45 billion.

Levi Strauss shares dipped 16.1% to $19.40 in pre-market trading.

Here are some big stocks recording losses in today's pre-market trading session.

Immutep Limited (NASDAQ:IMMP) shares tumbled 29.6% to $1.9493 in pre-market trading after Baird maintained an Outperform rating on the stock but lowered its price target from $7 to $6.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) fell 20.6% to $6.95 in pre-market trading after the company announced the pricing of a $200 million public offering of 30,769,230 shares at $6.50 per share.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) shares declined 15.4% to $13.25 in pre-market trading after the company reported mixed third-quarter results and lowered 2024 guidance below consensus estimates.
International Paper Company (NYSE:IP) shares slipped 11.5% to $41.05 in pre-market trading after Suzano said it will not pursue a transaction involving the company.
Grifols, S.A. (NASDAQ:GRFS) shares fell 10.8% to $6.21 in pre-market trading.
Hims & Hers Health, Inc. (NYSE:HIMS) fell 11.2% to $19.15 in pre-market trading after gaining over 8% on Tuesday.
Elanco Animal Health Incorporated (NYSE:ELAN) shares declined 6.7% to $16.76 in pre-market trading.
AeroVironment, Inc. (NASDAQ:AVAV) shares fell 6.1% to $181.00 in pre-market trading after the company reported fourth-quarter financial results and issued FY25 EPS guidance below estimates.

Now Read This: Over $30M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying

Don't forget to check out our premarket coverage here

Get the next $AVAV alert in real time by email

Recent Analyst Ratings for

Company	Date	Price Target	Rating	Analyst
AeroVironment Inc. $AVAV	11/20/2024	$240.00 → $230.00	Hold → Buy	Jefferies
Hims & Hers Health Inc. $HIMS	11/14/2024		Buy → Underperform	BofA Securities
International Paper Company $IP	11/13/2024	$48.20	Neutral → Underperform	Exane BNP Paribas
AeroVironment Inc. $AVAV	11/12/2024	$240.00	Buy → Hold	Jefferies
Elanco Animal Health Incorporated $ELAN	9/19/2024	$17.00 → $15.00	Overweight → Equal-Weight	Morgan Stanley
AeroVironment Inc. $AVAV	9/16/2024		Outperform → Mkt Perform	Raymond James
AeroVironment Inc. $AVAV	8/28/2024	$161.00 → $220.00	Neutral → Outperform	Robert W. Baird
AeroVironment Inc. $AVAV	8/28/2024	$216.00	Neutral → Overweight	Alembic Global Advisors

More analyst ratings

Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Chat with this insight

Recent Analyst Ratings for $AVAV$ELAN$GRFS$HIMS

$AVAV$ELAN$GRFS$HIMS Financials

Live finance-specific insights

AeroVironment to Acquire BlueHalo Establishing Next-Generation Defense Technology Company

AeroVironment, Inc. to Announce Second Quarter Fiscal Year 2025 Earnings and Host Conference Call

Elanco Acquires Speke Contract Manufacturing Facility, Securing Key Supply Chain

$AVAV$ELAN$GRFS$HIMS Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Commercial Officer Chi Michael exercised 7,500 shares at a strike of $13.90 and sold $165,000 worth of shares (7,500 units at $22.00) (SEC Form 4)

Chief Medical Officer Mauro David J covered exercise/tax liability with 4,187 shares, decreasing direct ownership by 2% to 225,429 units (SEC Form 4)

Chief Financial Officer Secora Michael covered exercise/tax liability with 11,937 shares, decreasing direct ownership by 0.80% to 1,487,694 units (SEC Form 4)

$AVAV$ELAN$GRFS$HIMS Press Releases

Fastest customizable press release news feed in the world

Hims & Hers Expands Nutrition Support to Fuel Customers' Weight Loss Journeys

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus

$AVAV$ELAN$GRFS$HIMS Market Insights

Live Market Insights

Jim Cramer: This Tech Stock Is 'Absolutely Terrific,' But Jumia? It's Not Making A Lot Of Money

Top 2 Consumer Stocks Which Could Rescue Your Portfolio In Q3

International Paper Sets Sights on Streamlined Success: Beats Q2 EPS Estimates Amid Sales Challenges

$AVAV$ELAN$GRFS$HIMS Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Manuel Anja bought $132,260 worth of shares (5,000 units at $26.45) (SEC Form 4)

Director Harrington Michael J bought $51,974 worth of shares (3,500 units at $14.85), increasing direct ownership by 5% to 81,094 units (SEC Form 4)

PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N bought $1,300,610 worth of shares (100,000 units at $13.01) (SEC Form 4)

$AVAV$ELAN$GRFS$HIMS Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

AeroVironment upgraded by Jefferies with a new price target

Hims & Hers Health downgraded by BofA Securities

Int'l Paper downgraded by Exane BNP Paribas with a new price target

$AVAV$ELAN$GRFS$HIMS Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by International Paper Company

Amendment: SEC Form SC 13G/A filed by Grifols S.A.

Amendment: SEC Form SC 13G/A filed by Recursion Pharmaceuticals Inc.

$AVAV$ELAN$GRFS$HIMS Leadership Updates

Live Leadership Updates

$AVAV$ELAN$GRFS$HIMS FDA approvals

Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

$AVAV$ELAN$GRFS$HIMS SEC Filings

Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions

Elanco Strengthens Board of Directors with Addition of Stacey Ma

Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors

September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

Hims & Hers Health Inc. filed SEC Form 8-K: Leadership Update

SEC Form 425 filed by AeroVironment Inc.

Recursion Pharmaceuticals Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits, ABS Informational and Computational Material

Recent Analyst Ratings for
$AVAV
$ELAN
$GRFS
$HIMS

$AVAV
$ELAN
$GRFS
$HIMS
Financials

$AVAV
$ELAN
$GRFS
$HIMS
Insider Trading

$AVAV
$ELAN
$GRFS
$HIMS
Press Releases

$AVAV
$ELAN
$GRFS
$HIMS
Market Insights

$AVAV
$ELAN
$GRFS
$HIMS
Insider Purchases

$AVAV
$ELAN
$GRFS
$HIMS
Analyst Ratings

$AVAV
$ELAN
$GRFS
$HIMS
Large Ownership Changes

$AVAV
$ELAN
$GRFS
$HIMS
Leadership Updates

$AVAV
$ELAN
$GRFS
$HIMS
FDA approvals

$AVAV
$ELAN
$GRFS
$HIMS
SEC Filings